PhenixFIN Corp Files 10-K/A Amendment for Fiscal Year Ended September 30, 2023

TL;DR

<b>PhenixFIN Corporation has filed an amendment to its 2023 10-K report, detailing its financial status and securities.</b>

AI Summary

PhenixFIN Corp (PFXNZ) filed a Amended Annual Report (10-K/A) with the SEC on January 26, 2024. PhenixFIN Corporation filed an amendment (10-K/A) to its annual report for the fiscal year ended September 30, 2023. The company's common stock is traded on the NASDAQ Global Market under the symbol PFX. PhenixFIN Corporation also has 5.25% Notes due 2028 registered and traded on the NASDAQ Global Market under the symbol PFXNZ. The company was incorporated in Delaware and its principal executive offices are located at 445 Park Avenue, New York, NY. The filing confirms the company has filed all required reports for the preceding 12 months and has been subject to filing requirements for the past 90 days.

Why It Matters

For investors and stakeholders tracking PhenixFIN Corp, this filing contains several important signals. This amendment provides updated information for the fiscal year ending September 30, 2023, which is crucial for investors to assess the company's performance and financial health. The inclusion of specific securities like common stock (PFX) and 5.25% Notes due 2028 (PFXNZ) traded on NASDAQ highlights the company's capital structure and investor base.

Risk Assessment

Risk Level: low — PhenixFIN Corp shows low risk based on this filing. The filing is an amendment to a 10-K, indicating it's an update to previously filed information rather than a new event, suggesting no immediate high-risk implications.

Analyst Insight

Investors should review the specific details within the 10-K/A amendment to understand any changes or clarifications made to PhenixFIN Corporation's financial reporting for the fiscal year ended September 30, 2023.

Key Numbers

• 2023-09-30 — Fiscal Year End (Fiscal Year Ended September 30, 2023)
• 2024-01-26 — Filing Date (Conformed Submission Type: 10-K/A Filed As Of Date)
• 5.25% — Note Interest Rate (5.25% Notes due 2028)

Key Players & Entities

• PhenixFIN Corporation (company) — Registrant
• NASDAQ Global Market (company) — Exchange where securities are registered
• PFX (company) — Trading symbol for Common Stock
• PFXNZ (company) — Trading symbol for 5.25% Notes due 2028
• Delaware (company) — State of Incorporation
• 445 Park Avenue (company) — Principal Executive Offices

FAQ

Risk Factors

• Reporting Requirements [low — regulatory]: The company confirms it has filed all required reports for the preceding 12 months and has been subject to such filing requirements for the past 90 days.

Industry Context

PhenixFIN Corporation operates within the financial services sector, likely as a business development company (BDC) given its former name 'Medley Capital BDC LLC'.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, indicating compliance with SEC regulations for public companies.

What Investors Should Do

1. Review the full 10-K/A filing for detailed financial statements and disclosures.
2. Monitor PFX and PFXNZ for any trading activity or news related to PhenixFIN Corporation.
3. Compare the information in this amendment with previous filings to identify significant changes.

Key Dates

• 2023-09-30: Fiscal Year End — The period covered by the 10-K/A filing.
• 2024-01-26: Filing Date — Date the amendment was filed with the SEC.

Year-Over-Year Comparison

This is an amendment (10-K/A) to the annual report, indicating updates or corrections to the original 10-K filing for the fiscal year ended September 30, 2023.

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share PFX NASDAQ Global Market

Filing Documents

• ef20019770_10ka.htm (10-K/A) — 265KB
• ef20019770_ex31-1.htm (EX-31.1) — 5KB
• ef20019770_ex31-2.htm (EX-31.2) — 5KB
• 0001140361-24-004061.txt (&nbsp;) — 557KB
• pfx-20230930.xsd (EX-101.SCH) — 4KB
• pfx-20230930_def.xml (EX-101.DEF) — 23KB
• pfx-20230930_lab.xml (EX-101.LAB) — 36KB
• pfx-20230930_pre.xml (EX-101.PRE) — 26KB
• ef20019770_10ka_htm.xml (XML) — 9KB

Directors, Executive Officers and Corporate Governance

Item 10. Directors, Executive Officers and Corporate Governance 1

Executive Compensation

Item 11. Executive Compensation 7

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 13

Certain Relationships and Related Transactions, and Director Independence

Item 13. Certain Relationships and Related Transactions, and Director Independence 14

Principal Accountant Fees and Services

Item 14. Principal Accountant Fees and Services 15 Part IV 16

Exhibits

Item 15. Exhibits 16 Table of Contents DOCUMENTS INCORPORATED BY REFERENCE None. EXPLANATORY NOTE PhenixFIN Corporation, a Delaware corporation, or together with its subsidiaries, where applicable, the Company, which may also be referred to as "we", "us" or "our", is filing this Amendment No. 1 (the "Amendment") to our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, which was filed with the SEC on December 22, 2023 (the "Form 10-K"). The purpose of this Form 10-K/A is solely to disclose the information required in Part III (Items 10, 11, 12, 13 and 14) of the Form 10-K, which information was previously omitted from the Form 10-K in reliance on General Instruction G(3) to Form 10-K. Accordingly, we hereby amend and replace in its entirety Part III of the Form 10-K. This Form 10-K/A does not amend any other information set forth in the Form 10-K, and we have not updated disclosures included therein to reflect any subsequent events. This Form 10-K/A should be read in conjunction with the Form 10-K and with our filings with the SEC subsequent to the Form 10-K. PART III Item 10. Directors, Executive Officers and Corporate Governance Our business and affairs are managed under the direction of our Board of Directors. The Board of Directors currently consists of five members, four of whom are not "interested persons" of the Company as defined in Section 2(a)(19) of the 1940 Act. We refer to these four individuals as our independent directors. Our Board of Directors elects our officers, who serve at the discretion of the Board of Directors. The responsibilities of each director include, among other things, oversight of our investment activity, quarterly valuation of our assets, and oversight of our financing arrangements. The Board of Directors has also established an audit committee, a nominating and corporate governance committee and a compensation committee and may establish additional committees in the future. Board of Directors

View Full Filing

View this 10-K/A filing on SEC EDGAR